Health
Ejaculation Frequency and Prostate Cancer: The '21 Times a Month' Study
Does ejaculating 21 times a month prevent prostate cancer? What the big US study really found, its limits, and why to avoid ejaculating before a PSA test.
Short answer
Higher ejaculation frequency is linked to a somewhat lower prostate cancer risk: in a US study of 31,925 men followed up to 18 years, 21 or more ejaculations a month meant about 20% lower risk than 4 to 7, mainly for low-risk cancer. It does not prove prevention. Avoid ejaculating for 48 hours before a PSA test.
Updated · sources listed at the end of this page
Key takeaways
- The '21 times a month' figure comes from the US Health Professionals Follow-up Study, which compared men reporting 21 or more ejaculations a month with men reporting 4 to 7.
- In the 2016 update of 31,925 men followed for up to 18 years, 21 or more ejaculations a month was linked to about a 20% lower risk of prostate cancer (hazard ratios 0.81 and 0.78), mainly low-risk cancer.
- The studies are observational and rely on men's memory of their habits, so they show an association, not that ejaculating more often prevents prostate cancer.
- Ejaculation can raise PSA temporarily: in one study it rose in 87% of men, and 97% were back to baseline by 48 hours.
- The NHS advises not ejaculating for 48 hours before a PSA test, and also avoiding vigorous exercise and cycling.
Ejaculation frequency and prostate cancer are linked in the large US study behind the "21 times a month" figure: men who reported 21 or more ejaculations a month had about a 20% lower risk of prostate cancer than men who reported 4 to 7, mostly for low-risk cancer (Rider et al., 2016). It is a real finding from a well-known cohort, but it is an association, not proof that ejaculating more often prevents cancer.
The practical point that matters more for most men is the opposite direction: ejaculating shortly before a PSA test can push the result up temporarily, and the NHS advises not ejaculating for 48 hours beforehand (NHS).
This page explains what the studies actually measured, what they cannot tell you and what to do with the information. It is part of our guide to ejaculation and your health, within our overview of how ejaculation works and its common problems.
Where does the "21 times a month" figure come from?
It comes from the Health Professionals Follow-up Study (HPFS), a long-running study of US male health professionals. In 1992, the men reported their average number of ejaculations per month, from intercourse, nocturnal emissions or masturbation, at ages 20 to 29, at ages 40 to 49 and in the previous year (Leitzmann et al., 2004).
The first analysis, published in 2004, followed 29,342 men aged 46 to 81 for 8 years. Most frequency categories made no difference to risk, but men who averaged 21 or more ejaculations a month across their lifetime had a lower risk than men with 4 to 7 (relative risk 0.67) (Leitzmann et al., 2004).
The 2016 update followed 31,925 men until 2010, up to 18 years, and recorded 3,839 prostate cancers (Rider et al., 2016). This is the study behind most headlines.
| Ejaculations per month (compared with 4 to 7) | Hazard ratio for prostate cancer (95% CI) |
|---|---|
| 21 or more, at ages 20 to 29 | 0.81 (0.72–0.92) |
| 21 or more, at ages 40 to 49 | 0.78 (0.69–0.89) |
Source: (Rider et al., 2016). A hazard ratio of 0.81 means about 19% lower risk over the follow-up period, and 0.78 about 22% lower. The lower risk was driven by low-risk prostate cancer, held in men who had PSA screening, and PSA testing and biopsy rates were similar across frequency groups (Rider et al., 2016).
"21" is simply the top category of the questionnaire, not a threshold where something changes in the prostate.
What do other studies show?
Other studies point in the same direction, but they differ in design and in which age mattered:
| Study | Who was studied | Main finding |
|---|---|---|
| HPFS 2016 update (cohort) | 31,925 US men, followed up to 18 years | 21+ a month linked to about 20% lower risk, mainly low-risk cancer (Rider et al., 2016) |
| HPFS 2004 (cohort) | 29,342 US men aged 46–81, 8 years | Lower risk with 21+ a month at ages 40–49 and averaged over life; no significant link at ages 20–29 or with advanced cancer (Leitzmann et al., 2004) |
| Australia (case-control) | Men diagnosed before 70 and matched controls | 5+ ejaculations a week in the 20s linked to lower risk (odds ratio 0.66) (Giles et al., 2003) |
| Spain, CAPLIFE (case-control) | 456 men with prostate cancer, 427 controls | 0–3 a month in the year before the interview linked to higher risk (odds ratio 2.38) than more than 4; the link was strongest for more aggressive and advanced tumours (Lozano-Lorca et al., 2023) |
Notice the inconsistencies. In the Australian study the protective link was strongest for ejaculation in the 20s (Giles et al., 2003), while in the first HPFS analysis the 20s showed no statistically significant link (relative risk 0.89, 95% CI 0.73–1.10) (Leitzmann et al., 2004). The Spanish study found the strongest link for the year before diagnosis (Lozano-Lorca et al., 2023), which raises a different question, covered below.
Does ejaculating more often prevent prostate cancer?
It has not been shown to. All of these studies are observational: they compare men who report different habits, and they cannot prove that the habit itself changes the risk. Several limitations matter:
- Self-report and memory. Frequency was reported by the men themselves, partly from memory decades back (Rider et al., 2016). In case-control studies, men with cancer may also remember their past differently from healthy men (Giles et al., 2003).
- Other differences between men. In the HPFS, men who ejaculated more often also differed in body mass index, physical activity, alcohol use, divorce and history of sexually transmitted infections (Rider et al., 2016). Statistical adjustment helps but cannot remove every difference.
- Reverse causation. An undiagnosed cancer, urinary symptoms or other health problems can reduce sexual activity. That may explain part of why the Spanish study's strongest finding concerned the year before diagnosis, when men with moderate urinary symptoms and low frequency had the highest risk (Lozano-Lorca et al., 2023).
- Who was studied. The HPFS participants were US health professionals, mostly white, which limits how far the results apply to other men (Rider et al., 2016).
- Mainly low-risk cancer. In the HPFS data the association was driven by low-risk disease (Rider et al., 2016), and the 2004 analysis found no significant link with advanced cancer (Leitzmann et al., 2004). In contrast, the Spanish CAPLIFE study found its strongest link for more aggressive and advanced tumours, although its case-control design makes reverse causation more likely (Lozano-Lorca et al., 2023).
Why ejaculation might matter biologically is still unknown. The Australian authors called the effects of infrequent ejaculation worth further research, and noted that the lack of any link with the number of sexual partners argues against infection as an explanation in their population (Giles et al., 2003).
The fair summary: there is no evidence that frequent ejaculation harms the prostate, and it is associated with a somewhat lower risk of prostate cancer, in the largest study mainly low-risk cancer. It is reassurance, not a prevention strategy, and it does not replace talking to a doctor about prostate checks.
Is ejaculating often bad for the prostate?
There is no evidence that it is. None of these studies found that frequent ejaculation raised prostate cancer risk. The original HPFS analysis concluded exactly that: ejaculation frequency is not related to an increased risk (Leitzmann et al., 2004). This also counters the idea, common in online "retention" communities, that frequent ejaculation is bad for the prostate.
The exception is pain. In men with chronic prostatitis or chronic pelvic pain syndrome, ejaculation relieves symptoms for some but makes them worse for others (Shoskes et al., 2004). If ejaculation hurts, that is a symptom to get checked, not a habit to push through; see painful ejaculation.
Can ejaculation increase PSA levels?
Yes, for a short time. Prostate-specific antigen (PSA) is a protein made by the prostate, measured in a blood test used to look for prostate problems, including cancer. Ejaculation releases some of it into the blood:
- In 64 men aged 49 to 79, PSA rose after ejaculation in 87% of them, by an average of 41% after one hour. Ninety-two percent were back to their baseline by 24 hours and 97% by 48 hours (Tchetgen et al., 1996).
- In 20 men with a normal PSA, 40% still had a total PSA above their baseline 24 hours after ejaculation, after allowing for normal variation (Herschman et al., 1997).
A falsely raised PSA can lead to worry, a repeat test or even further investigations you did not need. A high PSA does not necessarily mean cancer anyway; an enlarged prostate is one common alternative reason (NHS).
How long should you avoid ejaculating before a PSA test?
The NHS advises 48 hours, along with a few other precautions (NHS):
No ejaculation for 48 hours
Do not ejaculate in the 48 hours before the blood test. This matches the 48-hour recommendation of the study that measured how long PSA takes to settle (Tchetgen et al., 1996).
No vigorous exercise or cycling for 48 hours
Avoid anything that leaves you out of breath, such as exercise, and do not ride a bike. Anal sex should also be avoided in this window (NHS).
Mention any urine infection
A urine infection can affect the result. If you have one, the test is usually delayed until some weeks after it has cleared (NHS).
If the result is borderline, ask about a repeat
If you did ejaculate shortly before the test, tell your doctor, who can decide whether the test should be repeated under the right conditions.
In the UK, men and anyone with a prostate can ask a GP about PSA testing (NHS). Whether to be tested is a personal decision worth discussing with your doctor, because the test has benefits and drawbacks.
Does ejaculating help an enlarged prostate?
There is no good evidence that ejaculating treats an enlarged prostate (benign prostatic hyperplasia, or BPH). What is well documented is the reverse: some medicines for an enlarged prostate change ejaculation. Alpha-blockers are a recognised cause of retrograde ejaculation, where little or no semen comes out (NHS), and in a pooled analysis of 25 trials, silodosin raised the risk of retrograde ejaculation about 25-fold compared with placebo (Li et al., 2025). That side effect is not dangerous, but raise it with your doctor if it bothers you or you are trying to conceive.
Blood in semen in older men is one symptom where a prostate check is especially worthwhile: in a screening study of men mostly aged 50 and over, prostate cancer was found in 13.7% of those who reported it, compared with 6.5% of all men screened (Han et al., 2004). After accounting for age, PSA and examination findings, the link was borderline (odds ratio 1.73, not statistically significant) (Han et al., 2004). Our guide to blood in semen explains how the advice differs by age.
The bottom line
The "21 times a month" finding is real: in a large US study, men who ejaculated most often had about a 20% lower risk of prostate cancer, mainly low-risk cancer. But the evidence is observational, so it supports reassurance, not a quota: regular ejaculation has not been linked to harm, and it is not a substitute for prostate checks. The one firm practical rule is to avoid ejaculating for 48 hours before a PSA test.
Frequently asked questions
Do you need to ejaculate 21 times a month to prevent prostate cancer?
No. The number comes from the top category in a large US study, where men reporting 21 or more ejaculations a month had about a 20% lower risk than men reporting 4 to 7. It is an association, not a target, and it was strongest for low-risk cancer.
Does ejaculating prevent prostate cancer?
It has not been shown to. Several studies link more frequent ejaculation with a somewhat lower risk, but they are observational and cannot rule out other explanations. Regular ejaculation has not been linked to a higher prostate cancer risk, which is the safest conclusion.
Can ejaculation increase PSA levels?
Yes, temporarily. In a study of 64 men aged 49 to 79, PSA rose after ejaculation in 87%, and 97% were back to their baseline level within 48 hours. That is why the NHS advises not ejaculating for 48 hours before a PSA test.
Does ejaculating help an enlarged prostate?
There is no good evidence that it treats an enlarged prostate. Some medicines for an enlarged prostate reduce or stop the fluid at ejaculation, which is a known side effect worth discussing with your doctor.
Can ejaculating too often harm the prostate?
There is no evidence that it does: in the largest study, frequent ejaculation was not linked to a higher prostate cancer risk. If ejaculation is painful, that points to a problem such as prostatitis that should be checked.
Sources
- Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL (2016). Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. European Urology. Summary · doi:10.1016/j.eururo.2016.03.027
- Leitzmann MF, Platz EA, Stampfer MJ, Willett WC, Giovannucci E (2004). Ejaculation frequency and subsequent risk of prostate cancer. JAMA. Summary · doi:10.1001/jama.291.13.1578
- Giles GG, Severi G, English DR, McCredie MR, Borland R, Boyle P, Hopper JL (2003). Sexual factors and prostate cancer. BJU International. Summary · doi:10.1046/j.1464-410x.2003.04319.x
- Lozano-Lorca M, Olmedo-Requena R, Barrios-Rodríguez R, Jiménez-Pacheco A, Vázquez-Alonso F, Castillo-Bueno HM, Rodríguez-Barranco M, Jiménez-Moleón JJ (2023). Ejaculation Frequency and Prostate Cancer: CAPLIFE Study. World Journal of Men's Health. Summary · doi:10.5534/wjmh.220216
- Tchetgen MB, Song JT, Strawderman M, Jacobsen SJ, Oesterling JE (1996). Ejaculation increases the serum prostate-specific antigen concentration. Urology. Summary · doi:10.1016/S0090-4295(99)80486-5
- Herschman JD, Smith DS, Catalona WJ (1997). Effect of ejaculation on serum total and free prostate-specific antigen concentrations. Urology. Summary · doi:10.1016/S0090-4295(97)00209-4
- Shoskes DA, Landis JR, Wang Y, Nickel JC, Zeitlin SI, Nadler R; Chronic Prostatitis Collaborative Research Network Study Group (2004). Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. Journal of Urology. Summary · doi:10.1097/01.ju.0000132798.48067.23
- Li J, Ai C, Yuan C, Wang K, Yu L, Jian Z, Luo Q, Ma X (2025). Silodosin in Treating Men With BPH-Associated Lower Urinary Tract Symptoms: A Systematic Review and Network Meta-Analysis. International Journal of Surgery. Summary · doi:10.1097/JS9.0000000000004023
- Han M, Brannigan RE, Antenor JA, Roehl KA, Catalona WJ (2004). Association of hemospermia with prostate cancer. Journal of Urology. Summary · doi:10.1097/01.ju.0000144565.76243.b1
- NHS: PSA test
- NHS: Prostatitis
- NHS: Ejaculation problems
Keep reading
Health
Semen retention
Semen retention benefits checked against the evidence: testosterone, the retracted day-7 study, sperm quality, prostate health, NoFap and premature ejaculation.
Read · 7 min
Health
Ejaculation and age
At what age does a man stop ejaculating? There is no fixed age. How semen, timing, recovery and fertility change from your 40s on, and when to see a doctor.
Read · 6 min
Semen
Blood in semen
Blood in semen is usually harmless and often clears by itself. What causes it, what changes after 40, after a biopsy or vasectomy, and when to see a doctor.
Read · 7 min
Disorders
Painful ejaculation
Pain during or after ejaculation explained by where it hurts: urethra, perineum, testicles or groin. Common causes, the tests doctors use and what helps.
Read · 8 min